gadolinium has been researched along with Kidney Diseases in 136 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.47) | 18.7374 |
1990's | 11 (8.09) | 18.2507 |
2000's | 78 (57.35) | 29.6817 |
2010's | 37 (27.21) | 24.3611 |
2020's | 8 (5.88) | 2.80 |
Authors | Studies |
---|---|
Bu, S; Cao, Q; Ren, W; Wang, G; Xu, L; Zheng, H | 1 |
Aaseth, JO; Blomqvist, L; Nordberg, GF; Nurchi, VM | 1 |
Baldelomar, EJ; Bennett, KM; Charlton, JR | 1 |
Adams, W; El-Bulbul, J; Goldberg, A; Jawahar, A; Joyce, C; Yacoub, J | 1 |
Cheng, J; Coulthard, A; Sharma, P | 1 |
Dargan, PI; Layne, KA; Wood, DM | 1 |
Bruno, F; DeAguero, J; Do, C; Escobar, GP; Lee, DY; Tan, C; Wagner, B | 1 |
Borja, MJ; Dogra, S; Lui, YW | 1 |
Wagner, B | 1 |
Callahan, MJ; Iyer, RS; Lee, JJ; Maloney, E; Menon, S; Phillips, GS | 1 |
Do, C; Escobar, P; Ford, B; Lee, DY; Tan, C; Wagner, B | 1 |
Hiremath, S; Hurrell, C; Maralani, PJ; Schieda, N; Tsampalieros, AK | 1 |
Duan, SB; Liu, GL; Pan, P; Yu, ZQ | 1 |
Azar, SF; Chong, S; Elsayes, KM; Hussain, HK; Kappil, M; Liu, PS; Ruma, JA; Willatt, JM | 1 |
Calles Blanco, C; Carrasco Muñoz, S; Fernández Álvarez, C; Lafuente Martínez, J; Marcin, J | 1 |
Higaki, A; Ito, K; Kanki, A; Nishimura, H; Noda, Y; Sato, T; Tamada, T; Watanabe, S; Yamamoto, A | 1 |
Boulanger, T; Carsin-Nicole, B; Delmaire, C; Dhermain, F; Gerber, S; Le Rhun, E; Météllus, P; Petyt, G; Savatovsky, J | 1 |
Choi, JW; Rose, TA | 1 |
Åslund, PE; Nyman, RS; Nyman, UR; Swanberg, J | 1 |
Fukusato, T; Furui, S; Haruyama, T; Kanda, T; Kitajima, K; Kotoku, J; Matsuda, M; Oba, H; Toyoda, K | 1 |
Canale, D; de Bragança, AC; Girardi, AC; Gois, PH; Luchi, WM; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
Chen, W; Liang, C; Liang, L; Zhang, B; Zhang, S | 1 |
Sato, T | 1 |
Agris, J; Endrikat, J; Pietsch, H; Sieber, MA | 1 |
Arai, Y; Awai, K; Fukuda, K; Hayakawa, K; Hayashi, H; Ishiguchi, T; Kanematsu, M; Korogi, Y; Kuwatsuru, R; Murakami, T; Narumi, Y; Sugimoto, H; Takagi, R; Takehara, Y; Tsushima, Y; Yoshimitsu, K | 1 |
Barbieri, S; Froehlich, JM; Pasch, A; Schroeder, C; Thoeny, HC | 1 |
Costello, JR; Kalb, B; Martin, DR | 1 |
Martin, DR | 3 |
Altenburg, A; Borrmann, M; Grebe, SO; Haage, P; Hein, D; Wesselman, U | 1 |
Thomsen, HS | 1 |
Chen, MM; Coakley, FV; Kaimal, A; Laros, RK | 1 |
Pratt, RD; Smyth, MD | 1 |
Morcos, SK; Thomsen, HS | 1 |
Perazella, MA | 4 |
Halvorsen, RA | 1 |
Weinreb, JC | 1 |
Edelman, RD; Hamilton, BE; Jacobs, PM; Neuwelt, EA; Rooney, WR; Varallyay, CG; Watnick, SG | 1 |
Alam, MU; Alexander, MY; Canfield, AE; Kirton, JP; Martin, D; Riccardi, D; Rouhi, M; Sage, AP; Sinha, S; Towers, E; Vizard, TN; Ward, DT; Wilkinson, FL | 1 |
Agarwal, R; Brunelli, SM; Feldman, HI; Mitchell, MD; Umscheid, CA; Williams, K | 1 |
Fukuda, K; Hayashi, H; Horio, M; Hosoya, T; Ohno, I; Okada, H; Sugimoto, H; Tamura, S; Tsushima, Y | 1 |
Bardin, T; Richette, P | 1 |
Buckley, DL; Chrysochou, C; Cowie, A; Dark, P; Kalra, PA | 1 |
Jopp, HA | 1 |
Cattanéo, A; Goullé, JP; Guerbet, M; Lacroix, C; Mahieu, L; Saussereau, E | 1 |
Cianciulli, P; D'Ascola, D; Favilli, B; Filosa, A; Lombardi, M; Meloni, A; Pepe, A; Positano, V; Quarta, A; Restaino, G | 1 |
Breitschaft, A; Stahlmann, R | 1 |
Fukuda, K; Hayashi, H; Horio, M; Hosoya, T; Korogi, Y; Ohno, I; Okada, H; Sugimoto, H; Tamura, S; Tsushima, Y; Yoshifumi, N | 1 |
Berber, I; Cetinel, S; Eren, PA; Kara, M; Krand, O; Sehirli, O; Sener, G; Tellioglu, G; Titiz, I; Yildar, M | 1 |
Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE | 1 |
Chang, HJ | 1 |
Altmeyer, P; Becker, S; Daul, A; Hillen, U; Kreuter, A; Kribben, A; Napieralski, D; Rump, LC; Schieren, G; Walter, S; Wilde, B; Witzke, O | 1 |
Frøkiaer, J; Jørgensen, B; Jørgensen, TM; Karstoft, K; Pedersen, M; Rittig, S | 1 |
Fonda, JR; Gagnon, D; Kaufman, JS; Kim, KH; Lawler, EV | 1 |
Agarwal, SK; Rees, O | 1 |
Bulman, J; Klemm, B; Pandharipande, PV; Pedrosa, I; Rofsky, NM; Sena, BF; Stern, JP | 1 |
Pugliese, F | 1 |
Duncan, LM; Kagan, A; Kay, J; Mandal, RV; Nazarian, RM | 1 |
Manjunath, V; Perazella, MA | 1 |
Abu-Alfa, AK | 1 |
Britten, A; Craig, AJ; Heenan, SD; Irwin, AG | 1 |
Li, S; Lundervold, A; Merrem, AD; Peng, Y; Roervik, J; Schad, LR; Zöllner, FG | 1 |
Chien, CC; Chien, TW; Kan, WC; Lin, CY; Su, SB; Wang, HY; Wang, JJ | 1 |
Gulani, V; Nicholas, BA; Passalacqua, M; Ponsky, LE; Smith, M; Vricella, GJ | 1 |
Nadolski, GJ; Stavropoulos, SW | 1 |
Bianco, CC; Brinkman, WT; Bush, RL; Gunnoud, AB; Lin, PH; Lumsden, AB; Martin, LG; Terramani, TT; Weiss, VJ | 1 |
Almén, T; Elmståhl, B; Golman, K; Leander, P; Nilsson, M; Nyman, U | 1 |
Almèn, T; Morcos, SK; Thomsen, HS | 1 |
Morcos, SK | 2 |
Brinker, J | 1 |
Almén, T; Chai, CM; Elmståhl, B; Frennby, B; Leander, P; Nyman, U | 1 |
Buckley, DL; Cheung, CM; Hegarty, J; Kalra, PA; Mamtora, H; Middleton, RJ; Shurrab, AE | 1 |
Bettmann, M; Biguori, C; Briguori, C; Solomon, R | 1 |
Dacher, JN; Dolores, M; Gardin, I; Lefort, C; Marouteau-Pasquier, N; Vera, P; Vivier, PH | 1 |
Gerardin, E; Hervé, F; Lahaxe, L; Levesque, H; Marie, I; Robaday, S | 1 |
Israel, GM | 1 |
Grenier, N; Hauger, O; Pedersen, M | 1 |
Finsterer, J; Stöllberger, C | 1 |
Dharnidharka, VR; Fennell, RS; Wesson, SK | 1 |
Mitka, M | 1 |
Adusumilli, S; Carlos, RC; Ergen, FB; Francis, IR; Hussain, HK; Johnson, TD; Korobkin, M; Weadock, WJ | 1 |
Abdel-Rahman, MM; Abdel-Zaher, AO; Hafez, MM; Omran, FM | 1 |
Heaf, JG; Marckmann, P; Rossen, K; Skov, L; Thomsen, HS | 1 |
Heinrich, M; Uder, M | 1 |
Collidge, TA; Mark, PB; Thomson, PC; Traynor, JP | 1 |
Perazella, MA; Rodby, RA | 1 |
Bukhari, R; Mousa, D | 1 |
Abraham, JL; Alhariri, J; Thakral, C | 1 |
Nagy, J; Pintér, I; Vágási, K; Wittmann, I | 1 |
Cheng, S; Saab, G | 1 |
Logager, VB; Marckmann, P; Thomsen, HS | 1 |
Chibnik, LB; Kagan, A; Kay, J; Todd, DJ | 1 |
Bucala, R; Cowper, SE; Kuo, PH | 1 |
Aime, S; Canavese, C; Stratta, P | 2 |
Penfield, JG; Reilly, RF | 1 |
Matsuo, S; Shimizu, H; Tanaka, A | 1 |
Abraham, JL; Helm, TN; Kalb, RE; Kanal, E; Sperry, H; Thakral, C | 1 |
Abu-Alfa, A | 1 |
Reilly, RF | 1 |
Boehm, I | 1 |
Cowper, SE; Girardi, M; Rabach, M | 1 |
Bilecen, D; Bongartz, G; Mayr, M | 1 |
Marckmann, P; Thomsen, HS | 2 |
Abu-Alfa, A; Saab, G | 1 |
Bellin, MF; Van Der Molen, AJ | 1 |
Chan, LP; Kei, PL | 1 |
Stenver, DI | 1 |
Broome, DR | 1 |
Cowper, SE | 1 |
Brown, HH; Hiatt, K; High, WA; Horn, TD; Ranville, J; Shah, SV; Swaminathan, S; Thomas, M | 1 |
Frenzel, T; Lengsfeld, P; Pietsch, H; Schirmer, H; Sieber, MA; Siegmund, F; Walter, J; Weinmann, HJ | 1 |
Bhandari, M; Gujral, RB; Gupta, RK; Pandey, CM; Poptani, H; Sharma, RK | 1 |
Brown, ED; Semelka, RC | 1 |
Gibson, RJ; Meanock, CI; Torrie, EP; Walker, TM | 1 |
Debatin, JF; Huch Böni, RA; Krestin, GP | 1 |
Berg, KJ; Lundby, B; Nordal, KP; Reinton, V; Rootwelt, K; Smith, HJ | 1 |
Knesplova, L; Krestin, GP | 1 |
Ascher, SM; Hewes, LB; Patt, RH | 1 |
Bakker, J; Beek, FJ; Hené, RJ; Ligtenberg, G; van Reedt Dortland, RW | 1 |
Bigot, JM; Farres, MT; Flahault, A; Gattegno, B; Paula-Souza, R; Ronco, P | 1 |
Adam, GB; Günther, RW; Hübner, D; Nolte-Ernsting, CC; Rohrmann, D; Staatz, G; Stollbrink, C | 1 |
Becerra, CR; Carbone, DP; Frenkel, EP; Rosenthal, DI; Toto, RD | 1 |
Linsenmaier, U; Pfeifer, KJ; Rieger, J; Schiffl, H; Sitter, T; Toepfer, M | 1 |
Bernreuter, WK; Kenney, PJ; Listinsky, JJ; Morgan, DE; Rominger, MB | 1 |
Austin, HA; Choyke, PL; Frank, JA; Girton, ME | 1 |
Choyke, PL; Diggs, R; Frank, JA; Girton, ME; Morrison, P; Skinner, M | 1 |
Beyer, HK; Rühl, G; Uhlenbrock, D | 1 |
Felix, R; Fiegler, W; Köhler, D; Schörner, W | 1 |
46 review(s) available for gadolinium and Kidney Diseases
Article | Year |
---|---|
Gadolinium in Medical Imaging-Usefulness, Toxic Reactions and Possible Countermeasures-A Review.
Topics: Chelating Agents; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging | 2022 |
Where does the gadolinium go? A review into the excretion and retention of intravenous gadolinium.
Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2023 |
Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?
Topics: Chelation Therapy; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Treatment Outcome | 2020 |
Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.
Topics: Child; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Injections, Intravenous; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Premedication; Risk Assessment; Risk Factors; Surveys and Questionnaires | 2019 |
[Brain metastases imaging].
Topics: Brain Neoplasms; Carbon Radioisotopes; Carcinoma; Clinical Protocols; Contrast Media; Diagnostic Imaging; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Melanoma; Methionine; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2015 |
Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know.
Topics: Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Fibrosis; Gadolinium; Humans; Hypersensitivity, Immediate; Hypoglycemic Agents; Injections, Intravenous; Iodine Radioisotopes; Kidney; Kidney Diseases; Metformin; Radioisotopes | 2015 |
Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions.
Topics: Chelating Agents; Contrast Media; Drug Hypersensitivity; Evidence-Based Medicine; Gadolinium; Humans; Incidence; Internationality; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Survival Rate | 2016 |
Nephrogenic systemic fibrosis: more questions and some answers.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin; Skin Diseases | 2008 |
Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis.
Topics: Animals; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging | 2008 |
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Topics: Central Nervous System; Chronic Disease; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glomerular Filtration Rate; Humans; Iron; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanoparticles; Nephrogenic Fibrosing Dermopathy; Oxides; Risk Factors | 2009 |
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Dialysis | 2009 |
Rheumatic manifestations of renal disease.
Topics: Calcinosis; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Contrast Media; Gadolinium; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Rheumatic Diseases | 2009 |
Current status of gadolinium toxicity in patients with kidney disease.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Evidence-Based Medicine; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience.
Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Diseases; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Prognosis; United Kingdom | 2009 |
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm.
Topics: Acute Disease; Animals; Chronic Disease; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Risk Assessment; Risk Factors | 2009 |
MRI gadolinium-based contrast agents. Radiologists beware!
Topics: Chelating Agents; Contrast Media; Fibrosis; France; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging | 2009 |
[Nephrogenic systemic fibrosis].
Topics: Contrast Media; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Skin Diseases | 2009 |
Imaging patients with kidney disease in the era of NSF: can it be done safely?
Topics: Contrast Media; Diagnostic Imaging; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2011 |
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2011 |
Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
Topics: Algorithms; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radiographic Image Enhancement; Risk Factors; Tomography, X-Ray Computed | 2012 |
Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations.
Topics: Angiography; Carbon Dioxide; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Iodine; Kidney; Kidney Diseases; Radiography, Interventional; Risk Assessment; Risk Factors | 2013 |
Selection of contrast media.
Topics: Contrast Media; Gadolinium; Humans; Iodine; Kidney Diseases; Molecular Structure; Osmolar Concentration; Radiopharmaceuticals; Randomized Controlled Trials as Topic; X-Rays | 2006 |
Intravenous immunoglobulin-associated cranial pachymeningitis.
Topics: Adult; Dura Mater; Gadolinium; Humans; Immunoglobulins, Intravenous; Kidney Diseases; Magnetic Resonance Imaging; Male; Meningitis, Aseptic; Polyarteritis Nodosa; Radioisotopes; Tomography, X-Ray Computed | 2006 |
MRI of the kidney and urinary tract.
Topics: Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Image Processing, Computer-Assisted; Kidney Diseases; Magnetic Resonance Imaging; Urologic Diseases | 2006 |
Contrast agents for functional and cellular MRI of the kidney.
Topics: Contrast Media; Ferric Compounds; Gadolinium; Glomerular Filtration Rate; Humans; Image Processing, Computer-Assisted; Kidney Diseases; Kidney Tubules; Magnetic Resonance Imaging; Organometallic Compounds; Renal Circulation | 2006 |
[Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases | 2007 |
[Nephrogenic systemic fibrosis].
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Transplantation; Magnetic Resonance Imaging; Photopheresis; Plasmapheresis; Renal Dialysis; Skin; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: a nephrologist's perspective.
Topics: Contrast Media; Decision Making; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Insufficiency; Risk Factors | 2007 |
What nephrologists need to know about gadolinium.
Topics: Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrology | 2007 |
[Drug-induced nephropathy].
Topics: Aminoglycosides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Contrast Media; Creatinine; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Tubular Necrosis, Acute; Metabolic Clearance Rate | 2007 |
The impact of NSF on the care of patients with kidney disease.
Topics: Acidosis; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin; Skin Diseases | 2008 |
Nephrogenic system fibrosis: a radiologist's practical perspective.
Topics: Contrast Media; Documentation; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Humans; Informed Consent; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Risk Factors; Skin Diseases | 2008 |
Clinical and histological findings in nephrogenic systemic fibrosis.
Topics: Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Magnetic resonance angiography (MRA) in renally impaired patients: when and how.
Topics: Contrast Media; Decision Making; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Angiography; Skin Diseases | 2008 |
Extracellular Gd-CA: differences in prevalence of NSF.
Topics: Adverse Drug Reaction Reporting Systems; Contrast Media; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Prevalence; Registries; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis--implications for nephrologists.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin Diseases | 2008 |
Extracellular gadolinium contrast agents: differences in stability.
Topics: Contrast Media; Drug Stability; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Extracellular gadolinium-based contrast media: an overview.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Magnetic Resonance Imaging; Osmolar Concentration; Skin Diseases; Teratogens; Viscosity | 2008 |
Pharmacovigilance: what to do if you see an adverse reaction and the consequences.
Topics: Adverse Drug Reaction Reporting Systems; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Product Surveillance, Postmarketing; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Organ Specificity; Risk Factors; Skin Diseases | 2008 |
Gadolinium - is it to blame?
Topics: Contrast Media; Dermatology; Fibrosis; Gadolinium; Humans; Kidney Diseases; Pathology; Risk Assessment | 2008 |
Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Renal Insufficiency; Risk; Skin Diseases | 2008 |
Contrast-enhanced magnetic resonance imaging of the abdomen.
Topics: Abdomen; Contrast Media; Gadolinium; Gastrointestinal Diseases; Humans; Image Enhancement; Kidney Diseases; Liver Diseases; Magnetic Resonance Imaging; Pancreatic Diseases | 1994 |
Contrast-enhanced MR imaging of the kidneys and adrenal glands.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1996 |
Magnetic resonance in the assessment of renal function.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Magnetic Resonance Imaging; Microcirculation; Renal Circulation | 1998 |
Kidneys: combining morphology and function.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Pentetic Acid | 1993 |
5 trial(s) available for gadolinium and Kidney Diseases
Article | Year |
---|---|
A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.
Topics: Albumins; Blood Glucose; Contrast Media; Female; Furosemide; Gadolinium; Humans; Kidney Diseases; Male; Retrospective Studies; Risk Factors; ROC Curve | 2022 |
Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.
Topics: Adolescent; Adult; Child; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Hemoglobinopathies; Humans; Kidney Diseases; Male; Young Adult | 2009 |
Preoperative evaluation of living renal donors with gadolinium-enhanced magnetic resonance angiography.
Topics: Adult; Aged; Angiography, Digital Subtraction; Female; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Kidney Transplantation; Living Donors; Magnetic Resonance Angiography; Male; Middle Aged; Nephrectomy | 1999 |
Nonnephrotoxic, dynamic, contrast enhanced magnetic resonance urography: use in nephrology and urology.
Topics: Adult; Aged; Aged, 80 and over; Female; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Urography; Urologic Diseases | 2000 |
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.
Topics: Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Kidney Diseases; Male; Metalloporphyrins; Middle Aged; Neoplasms; Palliative Care; Radiation-Sensitizing Agents | 2000 |
85 other study(ies) available for gadolinium and Kidney Diseases
Article | Year |
---|---|
Mapping single-nephron filtration in the isolated, perfused rat kidney using magnetic resonance imaging.
Topics: Animals; Gadolinium; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Glomerulus; Magnetic Resonance Imaging; Nephrons; Rats | 2022 |
Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease.
Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2022 |
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis.
Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Fibrosis; Gadolinium; Kidney; Kidney Diseases; Mice; NADPH Oxidase 4; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2021 |
Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System; Cerebellar Nuclei; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pons; Retrospective Studies; Young Adult | 2021 |
Scared to the Marrow: Pitfalls and Pearls in Renal Imaging.
Topics: Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.
Topics: Animals; Bone Marrow Transplantation; Contrast Media; Diet, High-Fat; Female; Fibrosis; Gadolinium; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephrectomy; Random Allocation | 2019 |
Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists.
Topics: Canada; Contrast Media; Gadolinium; Humans; Image Enhancement; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Radiologists; Societies, Medical | 2019 |
Urinary KIM-1, IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients.
Topics: Aged; Biomarkers; Contrast Media; Creatinine; Cystatin C; Female; Gadolinium; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-18; Kidney Diseases; Male; Membrane Glycoproteins; Middle Aged; Receptors, Virus | 2013 |
MR imaging in the characterization of small renal masses.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2014 |
[Gadolinium-based contrast agents for magnetic resonance imaging].
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2014 |
Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Topics: Animals; Carbon Tetrachloride Poisoning; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Male; Mass Spectrometry; Nephrectomy; Rats; Rats, Wistar | 2015 |
Ultra-low iodine concentrations iso-attenuating with diagnostic 0.5M gadolinium in endovascular procedures to minimize the risk of contrast nephropathy: A phantom study.
Topics: Angiography; Contrast Media; Endovascular Procedures; Female; Fluoroscopy; Gadolinium; Humans; Iodine; Kidney Diseases; Male; Middle Aged; Phantoms, Imaging; Radiation Dosage; Tomography, X-Ray Computed | 2015 |
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
Topics: Autopsy; Brain; Contrast Media; Gadolinium; Humans; Kidney Diseases; Severity of Illness Index; Spectrophotometry, Atomic; Tissue Distribution | 2015 |
Vitamin D deficiency is a potential risk factor for contrast-induced nephropathy.
Topics: Animals; Contrast Media; Diabetic Nephropathies; Disease Models, Animal; Gadolinium; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats, Wistar; Risk Factors; Vitamin D; Vitamin D Deficiency | 2015 |
An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Meta-Analysis as Topic; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2015 |
Response to the Comments by Dr. Endrikat et al. on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Sh
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Male | 2016 |
Comments on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s1154
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Male | 2016 |
Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.
Topics: Breast Feeding; Contrast Media; Female; Gadolinium; Humans; Iodine; Japan; Kidney Diseases; Kidney Function Tests; Male; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Pregnancy; Risk Factors; Surveys and Questionnaires | 2016 |
High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
Topics: Aged; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Globus Pallidus; Humans; Kidney Diseases; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Vascular Calcification | 2016 |
Introduction.
Topics: Chelating Agents; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging | 2016 |
Chronic inflammation and accelerated atherosclerosis as important cofactors in nephrogenic systemic fibrosis following intravenous gadolinium exposure.
Topics: Atherosclerosis; Chronic Disease; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Inflammation; Kidney Diseases; Middle Aged; Time Factors | 2008 |
Is NSF only the tip of the "gadolinium toxicity" iceberg?
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation.
Topics: Abnormalities, Radiation-Induced; Acute Disease; Adult; Appendicitis; Cephalopelvic Disproportion; Colic; Contrast Media; Female; Fetus; Gadolinium; Humans; Kidney Diseases; Lactation; Magnetic Resonance Imaging; Obstetrics; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Radiation Dosage; Tomography, X-Ray Computed | 2008 |
Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'.
Topics: Chelating Agents; Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; United States; United States Food and Drug Administration; Uremia | 2008 |
Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging.
Topics: Anaphylaxis; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Hypersensitivity; Iodine; Kidney Diseases; Magnetic Resonance Imaging; Maternal-Fetal Exchange; Pregnancy; Tomography, X-Ray Computed | 2008 |
Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT?
Topics: Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Female; Fetus; Fibrosis; Gadolinium; Humans; Iodine; Kidney Diseases; Magnetic Resonance Imaging; Pregnancy; Tomography, X-Ray Computed | 2008 |
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.
Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Cattle; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Gadolinium; Humans; Kidney Diseases; Minerals; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing | 2009 |
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction].
Topics: Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Nephrogenic Fibrosing Dermopathy | 2008 |
[How safe are gadolinium-based contrast media? Nominal ranges for usage?].
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Kidney Diseases | 2009 |
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
Topics: Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Evaluation of gadolinium pre-treatment with or without splenectomy in the setting of renal ischemia reperfusion injury in rats.
Topics: Animals; Gadolinium; Kidney Diseases; Male; Rats; Rats, Wistar; Reperfusion Injury; Splenectomy | 2009 |
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors | 2010 |
Researchers focus on contrast safety.
Topics: Animals; Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Rats; Tomography, X-Ray Computed | 2010 |
The German registry for nephrogenic systemic fibrosis: findings from 23 patients.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Germany; Humans; Kidney Diseases; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Registries; Risk Factors | 2010 |
Structural and functional MRI in children with renal disease: first experience.
Topics: Adolescent; Algorithms; Child; Child, Preschool; Edetic Acid; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male | 2010 |
Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: a cross-sectional study of Veterans Affairs Health Care System data from 2005-2008.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Contrast Media; Creatinine; Cross-Sectional Studies; Databases, Factual; Drug Utilization; Female; Gadolinium; Glomerular Filtration Rate; Guideline Adherence; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; United States; United States Department of Veterans Affairs; United States Food and Drug Administration; Young Adult | 2010 |
Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media.
Topics: Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Guideline Adherence; Humans; Kidney Diseases; Magnetic Resonance Angiography; Male; National Health Programs; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Prognosis; Risk Assessment; Surveys and Questionnaires; United Kingdom | 2010 |
Screening patients to assess renal function before administering gadolinium chelates: assessment of the Choyke questionnaire.
Topics: Adult; Aged; Aged, 80 and over; Boston; Chelating Agents; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male; Mass Screening; Middle Aged; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires; Young Adult | 2010 |
Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
Topics: Adverse Drug Reaction Reporting Systems; Chronic Disease; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Patterns, Physicians'; United States; United States Food and Drug Administration | 2010 |
Gadolinium-enhanced coronary CT angiography: improved safety?
Topics: Contrast Media; Coronary Angiography; Gadolinium; Humans; Iodine Compounds; Kidney Diseases; Tomography, X-Ray Computed | 2010 |
Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
Topics: Adult; Aged; Biopsy; Cell Count; Contrast Media; Creatinine; Dermis; Female; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies | 2011 |
Significant differences when using MDRD for GFR estimation compared to radionuclide measured clearance.
Topics: Adult; Aged; Aged, 80 and over; Chromium Radioisotopes; Creatinine; Diet; Edetic Acid; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Regression Analysis; Reproducibility of Results; Retrospective Studies | 2011 |
Wavelet-based segmentation of renal compartments in DCE-MRI of human kidney: initial results in patients and healthy volunteers.
Topics: Algorithms; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Wavelet Analysis | 2012 |
Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment.
Topics: Acute Kidney Injury; Aged; Contrast Media; Female; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Risk Factors | 2011 |
Endovascular aortic aneurysm repair in patients with renal dysfunction or severe contrast allergy: utility of imaging modalities without iodinated contrast.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Rupture; Combined Modality Therapy; Contrast Media; Creatinine; Drug Hypersensitivity; Female; Follow-Up Studies; Gadolinium; Georgia; Humans; Incidence; Iodine; Kidney Diseases; Magnetic Resonance Angiography; Male; Radiographic Image Enhancement; Renal Dialysis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional; Vascular Surgical Procedures | 2002 |
Gadolinium contrast media for DSA in azotemia: are they really safer than iodinated agents?
Topics: Angiography, Digital Subtraction; Animals; Contrast Media; Gadolinium; Humans; Iodine; Kidney Diseases; Mice; Osmolar Concentration; Rats; Uremia | 2002 |
Gadolinium-containing contrast media for radiographic examinations: a position paper.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Lethal Dose 50; Rabbits; Radiography; Swine | 2002 |
Contrast nephrotoxicity and iso-osmolar contrast agents: implications of nephric.
Topics: Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Osmolar Concentration | 2004 |
Sometimes less is just less.
Topics: Coronary Angiography; Gadolinium; Humans; Kidney Diseases; Organometallic Compounds | 2004 |
Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs.
Topics: Angiography; Animals; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium; Half-Life; Image Processing, Computer-Assisted; Injections, Intra-Arterial; Iodine; Kidney; Kidney Diseases; Male; Osmolar Concentration; Swine; Time Factors | 2004 |
MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Cortex; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Regression Analysis; Renal Artery Obstruction | 2006 |
[Magnetic resonance urography in children].
Topics: Adolescent; Child; Child, Preschool; Contrast Media; France; Gadolinium; Humans; Hydronephrosis; Image Processing, Computer-Assisted; Infant; Infant, Newborn; Kidney Diseases; Kidney Diseases, Cystic; Kidney Function Tests; Magnetic Resonance Imaging; Syndrome; Ureteral Obstruction; Urodynamics; Urography | 2006 |
Dermal and extra-dermal manifestations of gadolinium-triggered nephrogenic fibrosing dermopathy.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Skin; Skin Diseases | 2006 |
Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients.
Topics: Child; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Skin; Skin Diseases | 2007 |
MRI contrast agents may pose risk for patients with kidney disease.
Topics: Comorbidity; Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk; Skin Diseases; Syndrome | 2007 |
Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
Topics: Case-Control Studies; Comorbidity; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Missouri; Renal Dialysis; Risk Factors; Skin Diseases | 2007 |
3D excretory MR urography: improved image quality with intravenous saline and diuretic administration.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diuretics; Furosemide; Gadolinium; Humans; Imaging, Three-Dimensional; Injections, Intravenous; Kidney Diseases; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Sodium Chloride; Urinary Tract; Urography | 2007 |
Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage.
Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Creatinine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gadolinium; Glutathione; Guanidines; Injections, Intramuscular; Kidney Diseases; Liver Diseases; Male; Nitric Oxide; Oleanolic Acid; Protective Agents; Rats; Rats, Wistar; Survival Analysis; Survival Rate | 2007 |
Case-control study of gadodiamide-related nephrogenic systemic fibrosis.
Topics: Case-Control Studies; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Reference Values | 2007 |
Gadolinium contrast may be risky in kidney disease.
Topics: Contrast Media; Fibromyalgia; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Angiography; Organometallic Compounds; Peripheral Vascular Diseases; Risk Factors | 2007 |
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
Topics: Fibrosis; Gadolinium; Humans; Kidney Diseases; Radioisotopes; Radiopharmaceuticals; Skin Diseases | 2007 |
Chronic kidney disease and stiff hands.
Topics: Adult; Chronic Disease; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Skin | 2007 |
Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
Topics: Adult; Bone and Bones; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin | 2007 |
Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Time Factors | 2007 |
Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fibrosis; Follow-Up Studies; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Skin; Skin Diseases; Syndrome | 2007 |
Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
Topics: Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Imaging; Radiopharmaceuticals; Skin; Skin Diseases | 2007 |
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate.
Topics: Chelating Agents; Contraindications; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; Skin Diseases; United States; United States Food and Drug Administration; Uremia | 2007 |
Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Topics: Contrast Media; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Skin; Skin Diseases; Treatment Outcome | 2008 |
Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis.
Topics: Aged; Contrast Media; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitals, Veterans; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Risk Assessment; Skin Diseases; Texas; Time Factors | 2008 |
Nephrogenic systemic fibrosis in patients undergoing hemodialysis: comment on the article by Todd et al.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Renal Dialysis; Skin Diseases | 2008 |
MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Gadolinium chelate-associated nephrogenic systemic fibrosis.
Topics: Contrast Media; Creatinine; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Scleroderma, Systemic; Singapore; Skin; Skin Diseases | 2008 |
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Patient Selection; Renal Dialysis; Risk Assessment; Skin Diseases; Time Factors | 2008 |
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Autopsy; Blood Vessels; Cardiovascular Diseases; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Kidney Diseases; Liver; Male; Middle Aged; Myocardium; Skin; Tissue Distribution | 2008 |
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.
Topics: Animals; Contrast Media; Copper; Fibrosis; Gadolinium; Gadolinium DTPA; Kidney Diseases; Ligands; Male; Organometallic Compounds; Rats; Skin Diseases; Statistics, Nonparametric; Tissue Distribution; Zinc | 2008 |
The magnetic resonance renogram in renal transplant evaluation using dynamic contrast-enhanced MR imaging.
Topics: Adult; Biopsy; Contrast Media; Cyclosporine; Female; Gadolinium; Gadolinium DTPA; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Radioisotope Renography; Transplantation, Homologous | 1995 |
An assessment of Gd-DTPA as a CT contrast agent in the renal tract.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1993 |
Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker.
Topics: Adult; Aged; beta 2-Microglobulin; Biomarkers; Contrast Media; Creatinine; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Half-Life; Humans; Injections, Intravenous; Iodine Radioisotopes; Iothalamic Acid; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1996 |
Feasibility and utility of respiratory-gated, gadolinium-enhanced T1-weighted magnetic resonance urography in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Gadolinium; Humans; Image Enhancement; Infant; Infant, Newborn; Kidney Diseases; Magnetic Resonance Imaging; Male; Respiration; Ureteral Diseases; Urography | 2000 |
Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Contrast Media; Creatinine; Female; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Safety | 2002 |
Gadolinium-enhanced MR imaging of renal masses.
Topics: Carcinoma, Renal Cell; Contrast Media; Cysts; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Kidney Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1992 |
Functional MR of the kidney.
Topics: Animals; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
Gadopentetate dimeglumine clearance in renal insufficiency in rabbits.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Kidney Diseases; Organometallic Compounds; Pentetic Acid; Rabbits | 1990 |
[Importance of contrast medium administration in determining the age of traumatic renal hemorrhage by NMR tomography--experimental results].
Topics: Animals; Diagnosis, Differential; Drug Evaluation, Preclinical; Gadolinium; Gadolinium DTPA; Hematoma; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains; Time Factors | 1988 |
[Diagnosis of kidney diseases with magnetic resonance tomography including the use of nuclear magnetic resonance contrast media].
Topics: Diagnosis, Differential; Gadolinium; Humans; Hydronephrosis; Kidney; Kidney Diseases; Kidney Diseases, Cystic; Kidney Neoplasms; Lipoma; Magnetic Resonance Spectroscopy; Nephritis; Pentetic Acid; Tomography, X-Ray Computed | 1985 |